ConductScience.org, home

Paper4698337

A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood.

Chiu J and 2 others. J Pediatr, 1973. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood. Papers, record 4698337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4698337

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood.
PubMed
Journal
J Pediatr
PubMed
Year
1973
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
2.17
iCite
Revised in PubMed
2019-06-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chiu JJ
2McLaine PNP N
3Drummond KNK N

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Nephrotic SyndromeMajor topic
PrednisoneMajor topic
Adolescent
Alopecia
Child
Cyclophosphamide
Cystitis
Drug Synergism
Female
Humans
Hypercholesterolemia
Hypoproteinemia
Leukopenia
Male
Prospective Studies
Proteinuria
Recurrence

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
39576325Prolonged remission after cyclophosphamide or tacrolimus treatment in childhood nephrotic syndrome: a cohort study.Pediatr Nephrol2025https://conductscience.org/library/papers/39576325PubMed
39513526Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.Cochrane Database Syst Rev2024https://conductscience.org/library/papers/39513526PubMed
32297308Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.Cochrane Database Syst Rev2020https://conductscience.org/library/papers/32297308PubMed
31145359Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome: A network meta-analysis of randomized controlled trials.Medicine (Baltimore)2019https://conductscience.org/library/papers/31145359PubMed
25785660Corticosteroid therapy for nephrotic syndrome in children.Cochrane Database Syst Rev2015https://conductscience.org/library/papers/25785660PubMed
15378419Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise?Pediatr Nephrol2005https://conductscience.org/library/papers/15378419PubMed
12716220The management of idiopathic nephrotic syndrome in children.Paediatr Drugs2003https://conductscience.org/library/papers/12716220PubMed
4425844Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.Br Med J1974https://conductscience.org/library/papers/4425844PubMed
3933709Long term effects of cyclophosphamide on testicular function.Br Med J (Clin Res Ed)1985https://conductscience.org/library/papers/3933709PubMed
3740921Minimal change nephrotic syndrome and cyclophosphamide.Arch Dis Child1986https://conductscience.org/library/papers/3740921PubMed
3688915Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie.Arch Dis Child1987https://conductscience.org/library/papers/3688915PubMed
2701868Immunosuppressive therapy in the nephrotic syndrome in children.Pediatr Nephrol1989https://conductscience.org/library/papers/2701868PubMed
2242303Testicular function following cyclophosphamide treatment for childhood nephrotic syndrome: long-term follow-up study.Pediatr Nephrol1990https://conductscience.org/library/papers/2242303PubMed
2040345The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies.Eur J Pediatr1991https://conductscience.org/library/papers/2040345PubMed
1718684Management of nephrotic syndrome in childhood.Drugs1991https://conductscience.org/library/papers/1718684PubMed
1616833Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome.Pediatr Nephrol1992https://conductscience.org/library/papers/1616833PubMed
1278059Clinical use of immunosuppressive drugs: part II.Drugs1976https://conductscience.org/library/papers/1278059PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4698337

GET https://conductscience.org/api/papers/v1/4698337/authors